Last deal

$5.7M

Amount

Series A

Stage

18.01.2023

Date

4

all rounds

$7.1M

Total amount

General

About Company
Biogenes is a medical device startup that produces diagnostic devices for infectious diseases using patented aptamer technologies.

Industry

Sector :

Subsector :

Also Known As

Biogenes

founded date

20.05.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Biogenes offers a range of aptamer-based diagnostic products, including DNA kits, buffers, diagnostic kits, Nano-coated sensor strips, and aptamers. Their new method allows for high volume production of diagnostic kits at low costs. Biogenes personalizes testing, allowing individuals to have better control of their health. They specialize in the design, development, and commercialization of aptamer-based biosensors for molecular diagnostics applications, with a focus on improving medical care through portable diagnosis.